TRAIL receptor deletion in mice suppresses the inflammation of nutrient excess

Journal of Hepatology

Volumn 62, Issue 5, 2015, Pages 1156-1163

  Idrissova, Leila ^a   Malhi, Harmeet ^a   Werneburg, Nathan W ^a   Lebrasseur, Nathan K ^a   Bronk, Steven F ^a   Fingas, Christian ^a   Tchkonia, Tamar ^a   Pirtskhalava, Tamar ^a   White, Thomas A ^a   Stout, Michael B ^a   Hirsova, Petra ^a   Krishnan, Anuradha ^a   Liedtke, Christian ^b   Trautwein, Christian ^b   Finnberg, Niklas ^c   El Deiry, Wafik S ^c   Kirkland, James L ^a   Gores, Gregory J ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PALMITIC ACID; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CONTROLLED STUDY; DIET INDUCED OBESITY; GENE DELETION; INFLAMMATION; INSULIN RESISTANCE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WEIGHT GAIN; WILD TYPE MOUSE; ANIMAL; CHEMOTAXIS; COMPLICATION; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; LIPID DIET; LIVER; MACROPHAGE; MACROPHAGE ACTIVATION; METABOLISM; OBESITY; PATHOLOGY; PROCEDURES;

ADIPOSE TISSUE; ANIMALS; CHEMOTAXIS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; INFLAMMATION; LIVER; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; OBESITY; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION;

EID: 84927797559     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.033     Document Type: Article

References (38)

1. S. Affo, M. Dominguez, J.J. Lozano, P. Sancho-Bru, D. Rodrigo-Torres, and O. Morales-Ibanez Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis Gut 62 2013 452 460
2. I.W. Asterholm, and P.E. Scherer Enhanced metabolic flexibility associated with elevated adiponectin levels Am J Pathol 176 2010 1364 1376
3. C.A. Benedict, and C.F. Ware TRAIL: not just for tumors anymore? J Exp Med 209 2012 1903 1906
4. S.C. Cazanave, J.L. Mott, S.F. Bronk, N.W. Werneburg, C.D. Fingas, and X.W. Meng Death receptor 5 signaling promotes hepatocyte lipoapoptosis J Biol Chem 286 2011 39336 39348
5. M. Charlton, A. Krishnan, K. Viker, S. Sanderson, S. Cazanave, and A. McConico Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition Am J Physiol Gastrointest Liver Physiol 301 2011 G825 G834
6. J.W. Choi, J.S. Song, and S.H. Pai Associations of serum TRAIL concentrations, anthropometric variables, and serum lipid parameters in healthy adults Ann Clin Lab Sci 34 2004 400 404
7. A. Collison, P.S. Foster, and J. Mattes Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses Clin Exp Pharmacol Physiol 36 2009 1049 1053
8. S.P. Cullen, C.M. Henry, C.J. Kearney, S.E. Logue, M. Feoktistova, and G.A. Tynan Fas/CD95-induced chemokines can serve as "Find-Me" signals for apoptotic cells Mol Cell 49 2013 1034 1048
9. G.E. Diehl, H.H. Yue, K. Hsieh, A.A. Kuang, M. Ho, and L.A. Morici TRAIL-R as a negative regulator of innate immune cell responses Immunity 21 2004 877 889
10. G.C. Farrell, C.Z. Larter, J.Y. Hou, R.H. Zhang, M.M. Yeh, and J. Williams Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression J Gastroenterol Hepatol 24 2009 443 452
11. A.E. Feldstein, A. Canbay, P. Angulo, M. Taniai, L.J. Burgart, and K.D. Lindor Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 2003 437 443
12. N. Finnberg, J.J. Gruber, P. Fei, D. Rudolph, A. Bric, and S.H. Kim DR5 knockout mice are compromised in radiation-induced apoptosis Mol Cell Biol 25 2005 2000 2013
13. M. Hatting, G. Zhao, F. Schumacher, G. Sellge, M.A. Masaoudi, and N. Gabetaler Hepatocyte caspase-8 is an essential modulator of steatohepatitis in mice Hepatology 57 2013 2189 2201
14. P. Hirsova, S.H. Ibrahim, S.F. Bronk, H. Yagita, and G.J. Gores Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis PLoS One 8 2013 e70599
15. J. Inoue, J. Gohda, and T. Akiyama Characteristics and biological functions of TRAF6 Adv Exp Med Biol 597 2007 72 79
16. R.W. Johnstone, A.J. Frew, and M.J. Smyth The TRAIL apoptotic pathway in cancer onset, progression and therapy Nat Rev Cancer 8 2008 782 798
17. S.D. Jordan, M. Kruger, D.M. Willmes, N. Redemann, F.T. Wunderlich, and H.S. Bronneke Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism Nat Cell Biol 13 2011 434 446
18. M. Keuper, I. Wernstedt Asterholm, P.E. Scherer, M.A. Westhoff, P. Moller, and K.M. Debatin TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma Cell Death Dis 4 2013 e474
19. M.I. Lefterova, and M.A. Lazar New developments in adipogenesis Trends Endocrinol Metab 20 2009 107 114
20. L. Liu, D. Brown, M. McKee, N.K. Lebrasseur, D. Yang, and K.H. Albrecht Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance Cell Metab 8 2008 310 317
21. H. Malhi, F.J. Barreyro, H. Isomoto, S.F. Bronk, and G.J. Gores Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity Gut 56 2007 1124 1131
22. H. Malhi, E.M. Kropp, V.F. Clavo, C.R. Kobrossi, J. Han, and A.S. Mauer C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis J Biol Chem 288 2013 18624 18642
23. K. Miura, L. Yang, N. van Rooijen, H. Ohnishi, and E. Seki Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2 Am J Physiol Gastrointest Liver Physiol 302 2012 G1310 G1321
24. B. Mundt, T. Wirth, L. Zender, M. Waltemathe, C. Trautwein, and M.P. Manns Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake Gut 54 2005 1590 1596
25. A.E. Obstfeld, E. Sugaru, M. Thearle, A.M. Francisco, C. Gayet, and H.N. Ginsberg C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis Diabetes 59 2010 916 925
26. J.I. Odegaard, and A. Chawla Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis Science 339 2013 172 177
27. D.Y. Oh, H. Morinaga, S. Talukdar, E.J. Bae, and J.M. Olefsky Increased macrophage migration into adipose tissue in obese mice Diabetes 61 2012 346 354
28. S.E. Shoelson, L. Herrero, and A. Naaz Obesity, inflammation, and insulin resistance Gastroenterology 132 2007 2169 2180
29. T. Tchkonia, T. Thomou, Y. Zhu, I. Karagiannides, C. Pothoulakis, and M.D. Jensen Mechanisms and metabolic implications of regional differences among fat depots Cell Metab 17 2013 644 656
30. R.H. Unger, G.O. Clark, P.E. Scherer, and L. Orci Lipid homeostasis, lipotoxicity and the metabolic syndrome Biochim Biophys Acta 1801 2010 209 214
31. D.M. Van Rooyen, L.T. Gan, M.M. Yeh, W.G. Haigh, C.Z. Larter, and G. Ioannou Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome J Hepatol 59 2013 144 152
32. N.L. Vujanovic Role of TNF superfamily ligands in innate immunity Immunol Res 50 2011 159 174
33. G. Wang, X. Wang, H. Yu, S. Wei, N. Williams, and D.L. Holmes Small-molecule activation of the TRAIL receptor DR5 in human cancer cells Nat Chem Biol 9 2013 84 89
34. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, and M.T. Huang Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat Immunol 12 2011 408 415
35. R.P. Witek, W.C. Stone, F.G. Karaca, W.K. Syn, T.A. Pereira, and K.M. Agboola Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis Hepatology 50 2009 1421 1430
36. G.S. Wu, T.F. Burns, Y. Zhan, E.S. Alnemri, and W.S. El-Deiry Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor Cancer Res 59 1999 2770 2775
37. S. Wueest, R.A. Rapold, D.M. Schumann, J.M. Rytka, A. Schildknecht, and O. Nov Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice J Clin Invest 120 2010 191 202
38. M.L. Yen, P.N. Hsu, H.J. Liao, B.H. Lee, and H.F. Tsai TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation PLoS One 7 2012 e38048